Semaglutide may lower burden of hospitalizations in high-risk patients

For patients at high cardiovascular risk with overweight or obesity, semaglutide is associated with reduced burden of total hospital admissions, according to a study published online in JAMA Cardiology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup